{"id": "article-26827_0", "title": "Pediatric Diabetic Ketoacidosis -- Continuing Education Activity", "content": "Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body\u2019s needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state. Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose: low blood glucose levels during fasting, starvation, vigorous exercise, or secondary to a defect in insulin production. This activity reviews the etiology, presentation, evaluation, and management of diabetic ketoacidosis in the pediatric population and examines the role of the interprofessional team in evaluating, diagnosing, and managing the condition.", "contents": "Pediatric Diabetic Ketoacidosis -- Continuing Education Activity. Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body\u2019s needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state. Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose: low blood glucose levels during fasting, starvation, vigorous exercise, or secondary to a defect in insulin production. This activity reviews the etiology, presentation, evaluation, and management of diabetic ketoacidosis in the pediatric population and examines the role of the interprofessional team in evaluating, diagnosing, and managing the condition."}
{"id": "article-26827_1", "title": "Pediatric Diabetic Ketoacidosis -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of pediatric diabetic ketoacidosis. Review the evaluation of a patient with pediatric diabetic ketoacidosis, including all necessary laboratory tests. Summarize the management options for diabetic ketoacidosis. Explain modalities to improve care coordination among interprofessional team members to improve outcomes for pediatric patients affected by diabetic ketoacidosis. Access free multiple choice questions on this topic.", "contents": "Pediatric Diabetic Ketoacidosis -- Continuing Education Activity. Objectives: Describe the pathophysiology of pediatric diabetic ketoacidosis. Review the evaluation of a patient with pediatric diabetic ketoacidosis, including all necessary laboratory tests. Summarize the management options for diabetic ketoacidosis. Explain modalities to improve care coordination among interprofessional team members to improve outcomes for pediatric patients affected by diabetic ketoacidosis. Access free multiple choice questions on this topic."}
{"id": "article-26827_2", "title": "Pediatric Diabetic Ketoacidosis -- Introduction", "content": "Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body's needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state. [1] [2] According to the International Society for Pediatric and Adolescent Diabetes, DKA is defined by the presence of all of the following in a patient with diabetes: Hyperglycemia \u2013 Blood glucose >200 mg/dL (11 mmol/L) Metabolic acidosis \u2013 Venous pH <7.3 or serum bicarbonate <15 mEq/L (15 mmol/L) Ketosis \u2013 Presence of ketones in the blood (>3 mmol/L beta-hydroxybutyrate) or urine (\"moderate or large\" urine ketones) [3]", "contents": "Pediatric Diabetic Ketoacidosis -- Introduction. Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body's needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state. [1] [2] According to the International Society for Pediatric and Adolescent Diabetes, DKA is defined by the presence of all of the following in a patient with diabetes: Hyperglycemia \u2013 Blood glucose >200 mg/dL (11 mmol/L) Metabolic acidosis \u2013 Venous pH <7.3 or serum bicarbonate <15 mEq/L (15 mmol/L) Ketosis \u2013 Presence of ketones in the blood (>3 mmol/L beta-hydroxybutyrate) or urine (\"moderate or large\" urine ketones) [3]"}
{"id": "article-26827_3", "title": "Pediatric Diabetic Ketoacidosis -- Introduction", "content": "Produced by the liver during fatty acid metabolism, KBs can be utilized by the brain, cardiac, and skeletal muscle tissues as a fuel when the body is deficient in or cannot effectively import glucose. [4] [5]", "contents": "Pediatric Diabetic Ketoacidosis -- Introduction. Produced by the liver during fatty acid metabolism, KBs can be utilized by the brain, cardiac, and skeletal muscle tissues as a fuel when the body is deficient in or cannot effectively import glucose. [4] [5]"}
{"id": "article-26827_4", "title": "Pediatric Diabetic Ketoacidosis -- Etiology", "content": "Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose (e.g., fasting, starvation, vigorous exercise, or secondary to a defect in insulin production). In type-2 DM, insulin production may be normal but below the level needed to shunt glucose into cells. [6] [7]", "contents": "Pediatric Diabetic Ketoacidosis -- Etiology. Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose (e.g., fasting, starvation, vigorous exercise, or secondary to a defect in insulin production). In type-2 DM, insulin production may be normal but below the level needed to shunt glucose into cells. [6] [7]"}
{"id": "article-26827_5", "title": "Pediatric Diabetic Ketoacidosis -- Etiology", "content": "Most body fat is stored as triglyceride (TG). When the body's glucose storage sites become depleted, the liver dismantles the TG into three fatty acids (FAs) and a glycerol molecule. The FAs can undergo oxidation while glycerol\u00a0converts to glucose. In the presence of enough insulin, this glucose will be consumed as energy. In the absence of insulin, the body cannot utilize the glucose released from the glycerol metabolism; unused glucose rises to dangerous levels, with spillover into the urine.", "contents": "Pediatric Diabetic Ketoacidosis -- Etiology. Most body fat is stored as triglyceride (TG). When the body's glucose storage sites become depleted, the liver dismantles the TG into three fatty acids (FAs) and a glycerol molecule. The FAs can undergo oxidation while glycerol\u00a0converts to glucose. In the presence of enough insulin, this glucose will be consumed as energy. In the absence of insulin, the body cannot utilize the glucose released from the glycerol metabolism; unused glucose rises to dangerous levels, with spillover into the urine."}
{"id": "article-26827_6", "title": "Pediatric Diabetic Ketoacidosis -- Etiology", "content": "When the blood glucose is\u00a0low or cannot be used due to a lack of insulin,\u00a0ketones are the major energy source for the brain. The brain does not store fuel\u00a0and can only utilize glucose and ketones for fuel. In contrast, skeletal muscle\u00a0stores and can utilize glycogen. Approximately 70% of the total body glycogen is stored in muscles and can be converted, when needed, to glucose via\u00a0glycogenolysis.", "contents": "Pediatric Diabetic Ketoacidosis -- Etiology. When the blood glucose is\u00a0low or cannot be used due to a lack of insulin,\u00a0ketones are the major energy source for the brain. The brain does not store fuel\u00a0and can only utilize glucose and ketones for fuel. In contrast, skeletal muscle\u00a0stores and can utilize glycogen. Approximately 70% of the total body glycogen is stored in muscles and can be converted, when needed, to glucose via\u00a0glycogenolysis."}
{"id": "article-26827_7", "title": "Pediatric Diabetic Ketoacidosis -- Epidemiology", "content": "DKA is frequently present at diagnosis of type 1 diabetes (in approximately 3% percent of children in the United States and Canada) and, along with its complications, is the most common cause of hospitalization, mortality, and morbidity in children with type 1 diabetes mellitus. [8] The fatality rate is approximately 0.15-0.31% of cases. DKA in children with type 2 diabetes is also observed but at lower rates. [9]", "contents": "Pediatric Diabetic Ketoacidosis -- Epidemiology. DKA is frequently present at diagnosis of type 1 diabetes (in approximately 3% percent of children in the United States and Canada) and, along with its complications, is the most common cause of hospitalization, mortality, and morbidity in children with type 1 diabetes mellitus. [8] The fatality rate is approximately 0.15-0.31% of cases. DKA in children with type 2 diabetes is also observed but at lower rates. [9]"}
{"id": "article-26827_8", "title": "Pediatric Diabetic Ketoacidosis -- Epidemiology", "content": "DKA at initial presentation of type 1 diabetes mellitus: DKA occurs at the time of diagnosis of type 1 diabetes in approximately 30 percent of children in the United States and Canada. [10] Factors that increase the likelihood of DKA at the initial presentation of type 1 diabetes in children are as follows: Young age (<5 years of age and especially <2 years) Ethnic minority Low socioeconomic status Children living in countries with a low prevalence of type 1 diabetes Ethnic minority Delayed diagnosis of diabetes [11] [12]", "contents": "Pediatric Diabetic Ketoacidosis -- Epidemiology. DKA at initial presentation of type 1 diabetes mellitus: DKA occurs at the time of diagnosis of type 1 diabetes in approximately 30 percent of children in the United States and Canada. [10] Factors that increase the likelihood of DKA at the initial presentation of type 1 diabetes in children are as follows: Young age (<5 years of age and especially <2 years) Ethnic minority Low socioeconomic status Children living in countries with a low prevalence of type 1 diabetes Ethnic minority Delayed diagnosis of diabetes [11] [12]"}
{"id": "article-26827_9", "title": "Pediatric Diabetic Ketoacidosis -- Epidemiology", "content": "The importance of socioeconomic status was observed in a review of 139 patients with newly diagnosed type 1 diabetes mellitus attended at a single center in the United States. [13] In addition, the frequency of DKA at the presentation of type 1 diabetes is shown to be inversely related to the prevalence of type 1 diabetes in the population, reflecting a greater frequency of missed diagnoses of type 1 diabetes. [14] DKA in established type 1 diabetes mellitus: In children with an established diagnosis of type 1 diabetes, DKA occurs at an annual rate of 6 to 8%. [15] [16] The following factors contribute to the development of DKA: Poor metabolic control Peripubertal and pubertal adolescent girls Gastroenteritis with vomiting and dehydration History of psychiatric disorders (including eating disorders) or family discord Limited access to medical care (underinsured) Omission of insulin, including failure of an insulin pump", "contents": "Pediatric Diabetic Ketoacidosis -- Epidemiology. The importance of socioeconomic status was observed in a review of 139 patients with newly diagnosed type 1 diabetes mellitus attended at a single center in the United States. [13] In addition, the frequency of DKA at the presentation of type 1 diabetes is shown to be inversely related to the prevalence of type 1 diabetes in the population, reflecting a greater frequency of missed diagnoses of type 1 diabetes. [14] DKA in established type 1 diabetes mellitus: In children with an established diagnosis of type 1 diabetes, DKA occurs at an annual rate of 6 to 8%. [15] [16] The following factors contribute to the development of DKA: Poor metabolic control Peripubertal and pubertal adolescent girls Gastroenteritis with vomiting and dehydration History of psychiatric disorders (including eating disorders) or family discord Limited access to medical care (underinsured) Omission of insulin, including failure of an insulin pump"}
{"id": "article-26827_10", "title": "Pediatric Diabetic Ketoacidosis -- Epidemiology", "content": "In a large prospective study in the United States, almost 60 percent of DKA episodes in children with established diabetes occurred in only 5 percent of all children. [15] Similar findings were reported in the United Kingdom. [8]", "contents": "Pediatric Diabetic Ketoacidosis -- Epidemiology. In a large prospective study in the United States, almost 60 percent of DKA episodes in children with established diabetes occurred in only 5 percent of all children. [15] Similar findings were reported in the United Kingdom. [8]"}
{"id": "article-26827_11", "title": "Pediatric Diabetic Ketoacidosis -- Epidemiology", "content": "DKA in type 2 diabetes mellitus: Ketosis and DKA can occur less frequently in children with type 2 diabetes and are usually observed mainly in African American adolescents with obesity. [17] About 13 percent had type 2 diabetes in a retrospective review of 69 patients (9 to 18 years of age) who presented with DKA. [9]", "contents": "Pediatric Diabetic Ketoacidosis -- Epidemiology. DKA in type 2 diabetes mellitus: Ketosis and DKA can occur less frequently in children with type 2 diabetes and are usually observed mainly in African American adolescents with obesity. [17] About 13 percent had type 2 diabetes in a retrospective review of 69 patients (9 to 18 years of age) who presented with DKA. [9]"}
{"id": "article-26827_12", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "The physiologic disturbance in DKA involves several interrelated processes:", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. The physiologic disturbance in DKA involves several interrelated processes:"}
{"id": "article-26827_13", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Hyperglycemia is present, which leads to serum hyperosmolarity and osmotic diuresis.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Hyperglycemia is present, which leads to serum hyperosmolarity and osmotic diuresis."}
{"id": "article-26827_14", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Glucosuria is the precursor to osmotic diuresis, hyperosmolarity, and dehydration. Free water losses can be substantial, with decompensation and impaired renal function.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Glucosuria is the precursor to osmotic diuresis, hyperosmolarity, and dehydration. Free water losses can be substantial, with decompensation and impaired renal function."}
{"id": "article-26827_15", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Ketones accumulate and cause metabolic acidosis. Compensatory hyperventilation eliminates carbon dioxide.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Ketones accumulate and cause metabolic acidosis. Compensatory hyperventilation eliminates carbon dioxide."}
{"id": "article-26827_16", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Approximate potassium deficits in children with DKA are 3 to 6 mEq/kg. However, serum potassium levels are usually normal or slightly elevated at presentation due to the shift of potassium ions from the intracellular to extracellular space. Osmotic diuresis, elevated aldosterone concentrations in response to intravascular volume depletion, and ketoacid excretion may also result in urinary potassium loss.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Approximate potassium deficits in children with DKA are 3 to 6 mEq/kg. However, serum potassium levels are usually normal or slightly elevated at presentation due to the shift of potassium ions from the intracellular to extracellular space. Osmotic diuresis, elevated aldosterone concentrations in response to intravascular volume depletion, and ketoacid excretion may also result in urinary potassium loss."}
{"id": "article-26827_17", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "The measured serum sodium is reduced by 1.6 mEq/L for every 100 mg/dL (5.5 mEq/L) increase in the blood glucose concentration above 100 mg/dL leading to pseudohyponatermia. [18]", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. The measured serum sodium is reduced by 1.6 mEq/L for every 100 mg/dL (5.5 mEq/L) increase in the blood glucose concentration above 100 mg/dL leading to pseudohyponatermia. [18]"}
{"id": "article-26827_18", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Glucosuria-induced osmotic diuresis also causes phosphate deficit in children. However, the serum phosphate concentration is usually normal or even slightly elevated initially\u00a0as\u00a0both metabolic acidosis and insulin deficiency cause extracellular phosphate\u00a0shift. As this transcellular shift reverses during DKA treatment, phosphate levels typically decline. [19]", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Glucosuria-induced osmotic diuresis also causes phosphate deficit in children. However, the serum phosphate concentration is usually normal or even slightly elevated initially\u00a0as\u00a0both metabolic acidosis and insulin deficiency cause extracellular phosphate\u00a0shift. As this transcellular shift reverses during DKA treatment, phosphate levels typically decline. [19]"}
{"id": "article-26827_19", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology", "content": "Elevated blood urea nitrogen (BUN) concentration may be found in patients with DKA, which correlates with the degree of hypovolemia. Acute increases in serum creatinine reflecting acute kidney injury (AKI) may also be observed.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology. Elevated blood urea nitrogen (BUN) concentration may be found in patients with DKA, which correlates with the degree of hypovolemia. Acute increases in serum creatinine reflecting acute kidney injury (AKI) may also be observed."}
{"id": "article-26827_20", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis", "content": "Glucose is the primary carbon-based substrate in blood necessary for the production of adenosine triphosphate (ATP), which is the energy currency of cells after glucose is metabolized during glycolysis, Kreb's cycle, and the electron transport chain. Ketone bodies are fat-derived fuels used by tissues at the time of limited glucose availability. Hepatic generation of ketone bodies is usually stimulated by the combination of low insulin levels and high counter-regulatory hormone levels, including glucagon. [20]", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis. Glucose is the primary carbon-based substrate in blood necessary for the production of adenosine triphosphate (ATP), which is the energy currency of cells after glucose is metabolized during glycolysis, Kreb's cycle, and the electron transport chain. Ketone bodies are fat-derived fuels used by tissues at the time of limited glucose availability. Hepatic generation of ketone bodies is usually stimulated by the combination of low insulin levels and high counter-regulatory hormone levels, including glucagon. [20]"}
{"id": "article-26827_21", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis", "content": "Deficiency and resistance (e.g., due to high catecholamine levels during physiological stress) lead to an unfavorable ratio of insulin to glucagon that activates hormone-sensitive lipase, which breaks down triglycerides in peripheral stores, releasing long-chain fatty acids and glycerol. The fatty acids, mainly bound to albumin, are transported to the splanchnic bed and taken up by hepatocytes. The fatty acids undergo beta-oxidation in the hepatic mitochondria and, by linking the fatty acid to coenzyme A (CoA), generate acetyl-CoA. The combination of low insulin and increased glucagon activity in the liver cells leads to the accelerated entry of the acyl-CoA into the mitochondria, mediated by a pair of carnitine palmityl transferase reactions. [21] [22] Acetyl coenzyme A can have one of three fates:", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis. Deficiency and resistance (e.g., due to high catecholamine levels during physiological stress) lead to an unfavorable ratio of insulin to glucagon that activates hormone-sensitive lipase, which breaks down triglycerides in peripheral stores, releasing long-chain fatty acids and glycerol. The fatty acids, mainly bound to albumin, are transported to the splanchnic bed and taken up by hepatocytes. The fatty acids undergo beta-oxidation in the hepatic mitochondria and, by linking the fatty acid to coenzyme A (CoA), generate acetyl-CoA. The combination of low insulin and increased glucagon activity in the liver cells leads to the accelerated entry of the acyl-CoA into the mitochondria, mediated by a pair of carnitine palmityl transferase reactions. [21] [22] Acetyl coenzyme A can have one of three fates:"}
{"id": "article-26827_22", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis", "content": "Enter the Krebs cycle to be oxidized to carbon dioxide (CO2) and water (H2O), forming adenosine triphosphate (ATP) Used to synthesize fatty acids in the cytoplasm Enter the ketogenic metabolic path to form acetoacetic acid", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis. Enter the Krebs cycle to be oxidized to carbon dioxide (CO2) and water (H2O), forming adenosine triphosphate (ATP) Used to synthesize fatty acids in the cytoplasm Enter the ketogenic metabolic path to form acetoacetic acid"}
{"id": "article-26827_23", "title": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis", "content": "With the generation of large quantities of acetyl-CoA in the more severe forms of each of these conditions, the oxidative capacity of the Krebs cycle gets saturated, and there is a spillover entry of acetyl-CoA into the ketogenic pathway and subsequent generation of acetoacetic acid, which is the first \"ketone body.\". The acetoacetic acid may then be reduced to beta-hydroxybutyric acid, which is also an organic acid, or nonenzymatically decarboxylated to acetone, which is not an acid. [23] Acetone does not convert back to acetyl-CoA; instead excreted through urine or exhaled.\u00a0Through this process, ketones provide an alternate water-soluble energy source when glucose availability is reduced.", "contents": "Pediatric Diabetic Ketoacidosis -- Pathophysiology -- Ketoacidosis. With the generation of large quantities of acetyl-CoA in the more severe forms of each of these conditions, the oxidative capacity of the Krebs cycle gets saturated, and there is a spillover entry of acetyl-CoA into the ketogenic pathway and subsequent generation of acetoacetic acid, which is the first \"ketone body.\". The acetoacetic acid may then be reduced to beta-hydroxybutyric acid, which is also an organic acid, or nonenzymatically decarboxylated to acetone, which is not an acid. [23] Acetone does not convert back to acetyl-CoA; instead excreted through urine or exhaled.\u00a0Through this process, ketones provide an alternate water-soluble energy source when glucose availability is reduced."}
{"id": "article-26827_24", "title": "Pediatric Diabetic Ketoacidosis -- Histopathology", "content": "Diabetes mellitus is a chronic illness; episodes of DKA recur in poorly controlled patients. It is difficult to characterize the consequences of\u00a0repeated episodes, but chronically elevated\u00a0HbA1c measurements predict micro-vascular and macro-vascular complications of diabetes.", "contents": "Pediatric Diabetic Ketoacidosis -- Histopathology. Diabetes mellitus is a chronic illness; episodes of DKA recur in poorly controlled patients. It is difficult to characterize the consequences of\u00a0repeated episodes, but chronically elevated\u00a0HbA1c measurements predict micro-vascular and macro-vascular complications of diabetes."}
{"id": "article-26827_25", "title": "Pediatric Diabetic Ketoacidosis -- Histopathology", "content": "Up to 1% of DKA patients will have cerebral edema due to rapid osmolar shifts. Look for signs of sudden increased\u00a0intracranial pressure: bradycardia, headache, papilledema, irritability, rising blood pressure, and decreasing Glasgow coma scale (GCS). Cerebral edema mortality approaches 25%. Survivors suffer significant neurological morbidity.", "contents": "Pediatric Diabetic Ketoacidosis -- Histopathology. Up to 1% of DKA patients will have cerebral edema due to rapid osmolar shifts. Look for signs of sudden increased\u00a0intracranial pressure: bradycardia, headache, papilledema, irritability, rising blood pressure, and decreasing Glasgow coma scale (GCS). Cerebral edema mortality approaches 25%. Survivors suffer significant neurological morbidity."}
{"id": "article-26827_26", "title": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics", "content": "Three ketone molecules predominate in human physiology: beta-hydroxybutyrate (BHB), acetoacetate, and acetone.", "contents": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics. Three ketone molecules predominate in human physiology: beta-hydroxybutyrate (BHB), acetoacetate, and acetone."}
{"id": "article-26827_27", "title": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics", "content": "Beta-hydroxybutyrate represents the most precise approach to measuring the severity of DKA, making up roughly 75% of ketones in DKA. Whole blood ketone test strips and serum laboratory tests quantify BHB. Most urine strips test for acetoacetate and acetone.", "contents": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics. Beta-hydroxybutyrate represents the most precise approach to measuring the severity of DKA, making up roughly 75% of ketones in DKA. Whole blood ketone test strips and serum laboratory tests quantify BHB. Most urine strips test for acetoacetate and acetone."}
{"id": "article-26827_28", "title": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics", "content": "BHB can be confirmed in the blood up to 24 hours before acetone and acetoacetate appear in the urine, as BHB is converted into these molecules. Therefore, urine ketone testing can increase even after proper DKA treatment ceases the formation of BHB. Acetone, which is stored in adipose tissue, is slowly released in the blood and excreted in the urine.", "contents": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics. BHB can be confirmed in the blood up to 24 hours before acetone and acetoacetate appear in the urine, as BHB is converted into these molecules. Therefore, urine ketone testing can increase even after proper DKA treatment ceases the formation of BHB. Acetone, which is stored in adipose tissue, is slowly released in the blood and excreted in the urine."}
{"id": "article-26827_29", "title": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics -- Serum Ketone Levels", "content": "Less than 0.6 mmol/L=normal Between 0.6\u00a0mmol/L\u00a0to 1.5 mmol/L=low to moderate Between 1.6\u00a0mmol/L\u00a0to 3.0 mmol/L=high with a risk of developing DKA Over 3.0 mmol/L: Likely DKA, requires immediate emergency treatment [24]", "contents": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics -- Serum Ketone Levels. Less than 0.6 mmol/L=normal Between 0.6\u00a0mmol/L\u00a0to 1.5 mmol/L=low to moderate Between 1.6\u00a0mmol/L\u00a0to 3.0 mmol/L=high with a risk of developing DKA Over 3.0 mmol/L: Likely DKA, requires immediate emergency treatment [24]"}
{"id": "article-26827_30", "title": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics -- Urine Ketone Strip Levels", "content": "Having no ketones in the urine is normal. One plus (+) ketones in urine ketones strips are equal to low/moderate blood ketones levels. Two plus (++) ketones in urine are equal to a high blood level of ketones. Three plus (+++) ketones in urine are equal to severe blood ketones. False-positive ketones in urine can occur with the intake of some medications like captopril and valproate. False-negative ketones in urine can occur\u00a0with expired urine strips or delayed urine testing. As mentioned above, blood ketone levels should be the first\u00a0choice to monitor the treatment. If blood testing is unavailable, urine ketone levels can help make the diagnosis but are of low yield in monitoring response to treatment. [25]", "contents": "Pediatric Diabetic Ketoacidosis -- Toxicokinetics -- Urine Ketone Strip Levels. Having no ketones in the urine is normal. One plus (+) ketones in urine ketones strips are equal to low/moderate blood ketones levels. Two plus (++) ketones in urine are equal to a high blood level of ketones. Three plus (+++) ketones in urine are equal to severe blood ketones. False-positive ketones in urine can occur with the intake of some medications like captopril and valproate. False-negative ketones in urine can occur\u00a0with expired urine strips or delayed urine testing. As mentioned above, blood ketone levels should be the first\u00a0choice to monitor the treatment. If blood testing is unavailable, urine ketone levels can help make the diagnosis but are of low yield in monitoring response to treatment. [25]"}
{"id": "article-26827_31", "title": "Pediatric Diabetic Ketoacidosis -- History and Physical", "content": "Ill patients with Type-1 DM should be evaluated for DKA, which can coexist with or be triggered by other acute illnesses (infection, trauma, etc.). There may be a history of polydipsia, polyuria, polyphagia (early), anorexia (late), weight loss, fatigue, or recurrent infection. Patients and parents may also report poor school performance, lack of concentration, altered mental status, and confusion as well. Commonly new-onset type 1 diabetic children appear thin and dehydrated on examination. Dehydration, thirst, and polyuria\u00a0are common at the time of presentation due to glucosuria and osmotic diuresis. Abdominal tenderness, abdominal pain, nausea, and vomiting are also common; some children in the first DKA episode may be misdiagnosed\u00a0with viral gastroenteritis. Patients with\u00a0metabolic acidosis classically display\u00a0rapid, deep breathing (Kussmaul respirations). The breath may have a fruity odor due to respiratory acetone elimination.", "contents": "Pediatric Diabetic Ketoacidosis -- History and Physical. Ill patients with Type-1 DM should be evaluated for DKA, which can coexist with or be triggered by other acute illnesses (infection, trauma, etc.). There may be a history of polydipsia, polyuria, polyphagia (early), anorexia (late), weight loss, fatigue, or recurrent infection. Patients and parents may also report poor school performance, lack of concentration, altered mental status, and confusion as well. Commonly new-onset type 1 diabetic children appear thin and dehydrated on examination. Dehydration, thirst, and polyuria\u00a0are common at the time of presentation due to glucosuria and osmotic diuresis. Abdominal tenderness, abdominal pain, nausea, and vomiting are also common; some children in the first DKA episode may be misdiagnosed\u00a0with viral gastroenteritis. Patients with\u00a0metabolic acidosis classically display\u00a0rapid, deep breathing (Kussmaul respirations). The breath may have a fruity odor due to respiratory acetone elimination."}
{"id": "article-26827_32", "title": "Pediatric Diabetic Ketoacidosis -- History and Physical", "content": "Neurologic findings range from alert, to lethargic and drowsy, to comatose correlated with\u00a0the extent of acidosis. [26]", "contents": "Pediatric Diabetic Ketoacidosis -- History and Physical. Neurologic findings range from alert, to lethargic and drowsy, to comatose correlated with\u00a0the extent of acidosis. [26]"}
{"id": "article-26827_33", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "DKA is definitively diagnosed by serology showing\u00a0metabolic acidosis and hyperglycemia. Ketone testing can be helpful but is not necessary. Several\u00a0point-of-care\u00a0and laboratory tests aid in the diagnosis of DKA. [27] These include:", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. DKA is definitively diagnosed by serology showing\u00a0metabolic acidosis and hyperglycemia. Ketone testing can be helpful but is not necessary. Several\u00a0point-of-care\u00a0and laboratory tests aid in the diagnosis of DKA. [27] These include:"}
{"id": "article-26827_34", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Anion gap: The anion gap is calculated as follows: (Na+K)-(Cl+HCO3). Ketoacids (primarily BHB) are unmeasured ions, leading to the \u201cgap\u201d in anions. The AG is normally between 6\u00a0mEq/L to\u00a012 mEq/L, with levels above 15 typically present in DKA. [28] [29] [30]", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Anion gap: The anion gap is calculated as follows: (Na+K)-(Cl+HCO3). Ketoacids (primarily BHB) are unmeasured ions, leading to the \u201cgap\u201d in anions. The AG is normally between 6\u00a0mEq/L to\u00a012 mEq/L, with levels above 15 typically present in DKA. [28] [29] [30]"}
{"id": "article-26827_35", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Blood glucose: It is usually above 200 mg/dL (11 mmol/l) and may be above 1000 mg/dL. Pediatric patients have\u00a0DKA with relatively\u00a0mild\u00a0elevations in blood glucose.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Blood glucose: It is usually above 200 mg/dL (11 mmol/l) and may be above 1000 mg/dL. Pediatric patients have\u00a0DKA with relatively\u00a0mild\u00a0elevations in blood glucose."}
{"id": "article-26827_36", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Serum BHB concentration: BHB is usually above\u00a031 mg/dL in these patients. [31]", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Serum BHB concentration: BHB is usually above\u00a031 mg/dL in these patients. [31]"}
{"id": "article-26827_37", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Blood urea nitrogen (BUN) and creatinine", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Blood urea nitrogen (BUN) and creatinine"}
{"id": "article-26827_38", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Serum electrolytes", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Serum electrolytes"}
{"id": "article-26827_39", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Venous pH and partial pressure of carbon dioxide (pCO2): A pH below 7.2 portends a worse prognosis and often indicates the need for intensive care unit admission.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Venous pH and partial pressure of carbon dioxide (pCO2): A pH below 7.2 portends a worse prognosis and often indicates the need for intensive care unit admission."}
{"id": "article-26827_40", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Urinary ketone: Nitroprusside test strip reacts with acetoacetate and acetone but not BHB. Though less accurate and precise, many health centers use urine test strips for diagnosis.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Urinary ketone: Nitroprusside test strip reacts with acetoacetate and acetone but not BHB. Though less accurate and precise, many health centers use urine test strips for diagnosis."}
{"id": "article-26827_41", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Blood lactate concentration: The presence of lactate can help rule out lactic acidosis. It is also an important prognostic marker in the presence of sepsis, which may be a precipitating cause in many DKA patients.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Blood lactate concentration: The presence of lactate can help rule out lactic acidosis. It is also an important prognostic marker in the presence of sepsis, which may be a precipitating cause in many DKA patients."}
{"id": "article-26827_42", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Hemoglobin A1c (HbA1c): This is helpful\u00a0in patients with known diabetes to evaluate the degree of glucose control.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Hemoglobin A1c (HbA1c): This is helpful\u00a0in patients with known diabetes to evaluate the degree of glucose control."}
{"id": "article-26827_43", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Diabetes-associated antibodies: Glutamic acid decarboxylase antibodies, insulin autoantibodies, islet cell antibodies, and zinc transporter 8 antibodies are not useful for managing DKA. However, their presence confirms the diagnosis of type 1 diabetes mellitus in 80 to 85% of\u00a0new patients. [32]", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Diabetes-associated antibodies: Glutamic acid decarboxylase antibodies, insulin autoantibodies, islet cell antibodies, and zinc transporter 8 antibodies are not useful for managing DKA. However, their presence confirms the diagnosis of type 1 diabetes mellitus in 80 to 85% of\u00a0new patients. [32]"}
{"id": "article-26827_44", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "C-peptide levels: It is a useful marker of beta-cell function, allowing discrimination between insulin-sufficient and insulin-deficient individuals with diabetes. A value of less than 0.2\u00a0nmol/l is associated with a diagnosis of type 1 diabetes mellitus (T1DM).", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. C-peptide levels: It is a useful marker of beta-cell function, allowing discrimination between insulin-sufficient and insulin-deficient individuals with diabetes. A value of less than 0.2\u00a0nmol/l is associated with a diagnosis of type 1 diabetes mellitus (T1DM)."}
{"id": "article-26827_45", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "DKA can be categorized as mild, moderate, and severe based on the following criteria: Table 1. The severity of diabetic ketoacidosis in children", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. DKA can be categorized as mild, moderate, and severe based on the following criteria: Table 1. The severity of diabetic ketoacidosis in children"}
{"id": "article-26827_46", "title": "Pediatric Diabetic Ketoacidosis -- Evaluation", "content": "Higher thresholds for bicarbonate may be used for vulnerable patients such as those in resource-limited settings or in young children, e.g., bicarbonate <7 mEq/L for severe DKA and <18 mEq/L for mild DKA.", "contents": "Pediatric Diabetic Ketoacidosis -- Evaluation. Higher thresholds for bicarbonate may be used for vulnerable patients such as those in resource-limited settings or in young children, e.g., bicarbonate <7 mEq/L for severe DKA and <18 mEq/L for mild DKA."}
{"id": "article-26827_47", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Treatment for DKA begins with ABCs and fluid resuscitation. Insulin therapy, usually by continuous infusion, can begin once the patient is stabilized. [1] [33] [34] [35]", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Treatment for DKA begins with ABCs and fluid resuscitation. Insulin therapy, usually by continuous infusion, can begin once the patient is stabilized. [1] [33] [34] [35]"}
{"id": "article-26827_48", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "General resuscitation: Provide\u00a0100% oxygen and consider intubation if needed. Insert a nasogastric tube and urinary catheter for comatose patients. Reliable intravenous (IV) access (preferably two large-bore accesses) should be obtained, one for insulin treatment and the other for blood samples and other medications.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. General resuscitation: Provide\u00a0100% oxygen and consider intubation if needed. Insert a nasogastric tube and urinary catheter for comatose patients. Reliable intravenous (IV) access (preferably two large-bore accesses) should be obtained, one for insulin treatment and the other for blood samples and other medications."}
{"id": "article-26827_49", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Clinical assessment: Identify any signs of infection or other precipitating causes and treat as indicated.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Clinical assessment: Identify any signs of infection or other precipitating causes and treat as indicated."}
{"id": "article-26827_50", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Precise patient weight is necessary for calculating insulin and other medication dosing.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Precise patient weight is necessary for calculating insulin and other medication dosing."}
{"id": "article-26827_51", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Insulin Therapy: Regular Insulin should be administered with a continuous drip at a rate of 0.1 unit/kg/hour. [27] Subcutaneous insulin may be used in case of milder diabetic ketoacidosis or when IV infusion pumps are unavailable. Dextrose should be added to the IV fluid infusion when serum glucose concentration decreases to 250 mg/dL. [27] Higher concentrations of dextrose may be used, for example, 10 to 12.5%, when the blood glucose level falls below 150 mg/dL. This allows for complete resolution of ketoacidosis with continued insulin infusion. Ideally, the insulin infusion rate is reduced only after ketoacidosis is corrected or nearly corrected. However, in malnourished patients with increased sensitivity to insulin, insulin infusion rates may be decreased to avoid hypoglycemia. There is no role for insulin bolus in pediatric DKA patients \u2013 this is thought to increase the risk of cerebral edema. Consider waiting to initiate insulin infusion until after serum potassium is known, thus preventing critical worsening of hypokalemia.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Insulin Therapy: Regular Insulin should be administered with a continuous drip at a rate of 0.1 unit/kg/hour. [27] Subcutaneous insulin may be used in case of milder diabetic ketoacidosis or when IV infusion pumps are unavailable. Dextrose should be added to the IV fluid infusion when serum glucose concentration decreases to 250 mg/dL. [27] Higher concentrations of dextrose may be used, for example, 10 to 12.5%, when the blood glucose level falls below 150 mg/dL. This allows for complete resolution of ketoacidosis with continued insulin infusion. Ideally, the insulin infusion rate is reduced only after ketoacidosis is corrected or nearly corrected. However, in malnourished patients with increased sensitivity to insulin, insulin infusion rates may be decreased to avoid hypoglycemia. There is no role for insulin bolus in pediatric DKA patients \u2013 this is thought to increase the risk of cerebral edema. Consider waiting to initiate insulin infusion until after serum potassium is known, thus preventing critical worsening of hypokalemia."}
{"id": "article-26827_52", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "The i nsulin infusion is stopped when the following targets are achieved: The patient can take orally administered medications Blood glucose less than 200 mg/dL Serum anion gap closed or BHB less than or equal to 10.4 mg/dL Venous pH >7.3 or serum bicarbonate >15 mEq/L", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. The i nsulin infusion is stopped when the following targets are achieved: The patient can take orally administered medications Blood glucose less than 200 mg/dL Serum anion gap closed or BHB less than or equal to 10.4 mg/dL Venous pH >7.3 or serum bicarbonate >15 mEq/L"}
{"id": "article-26827_53", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "IV Fluids:\u00a0 Treats dehydration and also hyperglycemia. Initial IV fluid bolus of 10 mL/kg of normal saline or lactated ringers. If the patient presents with shock, a second 10 mL/kg IV fluid bolus may be given.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. IV Fluids:\u00a0 Treats dehydration and also hyperglycemia. Initial IV fluid bolus of 10 mL/kg of normal saline or lactated ringers. If the patient presents with shock, a second 10 mL/kg IV fluid bolus may be given."}
{"id": "article-26827_54", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "As mentioned above, hyperglycemia contributes to pseudohyponatremia. Therefore sodium should\u00a0be continuously monitored, and higher concentrations of sodium should be used in IV fluids if sodium levels do not improve or continue to fall with treatment. [36]", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. As mentioned above, hyperglycemia contributes to pseudohyponatremia. Therefore sodium should\u00a0be continuously monitored, and higher concentrations of sodium should be used in IV fluids if sodium levels do not improve or continue to fall with treatment. [36]"}
{"id": "article-26827_55", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Potassium replacement should depend on close observation and interpretation of lab values. If the initial potassium level reveals hyperkalemia, potassium replacement should be held until potassium normalizes, urinary voiding is confirmed to be intact, and there is normal renal function.\u00a0 Normal initial potassium in an acidotic patient could indicate severely low total body potassium. Patients with normal or low\u00a0serum potassium require\u00a0replacement after ruling out renal dysfunction. DKA\u00a0patients with hypokalemia should have delayed initial insulin infusion; potassium replacement should precede insulin dosing as above. [27] The serum potassium concentration and electrocardiogram can be used for monitoring as needed.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Potassium replacement should depend on close observation and interpretation of lab values. If the initial potassium level reveals hyperkalemia, potassium replacement should be held until potassium normalizes, urinary voiding is confirmed to be intact, and there is normal renal function.\u00a0 Normal initial potassium in an acidotic patient could indicate severely low total body potassium. Patients with normal or low\u00a0serum potassium require\u00a0replacement after ruling out renal dysfunction. DKA\u00a0patients with hypokalemia should have delayed initial insulin infusion; potassium replacement should precede insulin dosing as above. [27] The serum potassium concentration and electrocardiogram can be used for monitoring as needed."}
{"id": "article-26827_56", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Ketoacidosis is resolved when the anion gap is normal, serum BHB is \u226410.4 mg/dL, and venous pH is \u22657.3. It is achieved through decreased hepatic production of ketones, enhanced metabolism by insulin, and increased removal by improved rehydration. [27] [37]", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Ketoacidosis is resolved when the anion gap is normal, serum BHB is \u226410.4 mg/dL, and venous pH is \u22657.3. It is achieved through decreased hepatic production of ketones, enhanced metabolism by insulin, and increased removal by improved rehydration. [27] [37]"}
{"id": "article-26827_57", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Lactic acidosis is also corrected with improved rehydration.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Lactic acidosis is also corrected with improved rehydration."}
{"id": "article-26827_58", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Bicarbonate therapy is generally avoided in\u00a0children with DKA except in peri-arrest or cardiac arrest patients, life-threatening hyperkalemia, or severe acidosis (pH <6.9 with symptoms).", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Bicarbonate therapy is generally avoided in\u00a0children with DKA except in peri-arrest or cardiac arrest patients, life-threatening hyperkalemia, or severe acidosis (pH <6.9 with symptoms)."}
{"id": "article-26827_59", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "High-level nursing and frequent clinical assessments are necessary; biochemical blood markers every two hours.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. High-level nursing and frequent clinical assessments are necessary; biochemical blood markers every two hours."}
{"id": "article-26827_60", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Once acidosis is resolved, the anion gap has closed, and the patient is improving clinically, then diet can be reintroduced, and insulin can be switched to subcutaneous injection. Long-acting/baseline insulin should be administered prior to discontinuation of the infusion.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Once acidosis is resolved, the anion gap has closed, and the patient is improving clinically, then diet can be reintroduced, and insulin can be switched to subcutaneous injection. Long-acting/baseline insulin should be administered prior to discontinuation of the infusion."}
{"id": "article-26827_61", "title": "Pediatric Diabetic Ketoacidosis -- Treatment / Management", "content": "Prevention: Determine the cause of the acute DKA episode and work closely with the child and caregivers on a regime.", "contents": "Pediatric Diabetic Ketoacidosis -- Treatment / Management. Prevention: Determine the cause of the acute DKA episode and work closely with the child and caregivers on a regime."}
{"id": "article-26827_62", "title": "Pediatric Diabetic Ketoacidosis -- Differential Diagnosis", "content": "Gastroenteritis Hyperosmolar hyperglycemic nonketotic syndrome Starvation ketosis Myocardial infarction Pancreatitis Alcoholic ketoacidosis Lactic acidosis Sepsis Toxicologic exposure (ethylene glycol, methanol, paraldehyde, salicylate) Diabetic medication overdose Uremia Respiratory acidosis Respiratory distress syndrome", "contents": "Pediatric Diabetic Ketoacidosis -- Differential Diagnosis. Gastroenteritis Hyperosmolar hyperglycemic nonketotic syndrome Starvation ketosis Myocardial infarction Pancreatitis Alcoholic ketoacidosis Lactic acidosis Sepsis Toxicologic exposure (ethylene glycol, methanol, paraldehyde, salicylate) Diabetic medication overdose Uremia Respiratory acidosis Respiratory distress syndrome"}
{"id": "article-26827_63", "title": "Pediatric Diabetic Ketoacidosis -- Prognosis", "content": "Prognosis improves with advances in medical and intensive care. Mortality rates range from 0.15 to 0.31% in the United States and other resource-developed countries like Canada and United Kingdom. [38] The majority of deaths result from cerebral injury. [39] Mortality rates or higher and resource-limited settings.", "contents": "Pediatric Diabetic Ketoacidosis -- Prognosis. Prognosis improves with advances in medical and intensive care. Mortality rates range from 0.15 to 0.31% in the United States and other resource-developed countries like Canada and United Kingdom. [38] The majority of deaths result from cerebral injury. [39] Mortality rates or higher and resource-limited settings."}
{"id": "article-26827_64", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "The most feared complication of pediatric DKA is cerebral injury/cerebral edema:", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. The most feared complication of pediatric DKA is cerebral injury/cerebral edema:"}
{"id": "article-26827_65", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Develops in 0.3%-0.9% of pediatric DKA cases. [38]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Develops in 0.3%-0.9% of pediatric DKA cases. [38]"}
{"id": "article-26827_66", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Mortality ranges from 21-24% [38] [40] [41] [40] [38]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Mortality ranges from 21-24% [38] [40] [41] [40] [38]"}
{"id": "article-26827_67", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Risk factors:\u00a0 Severe acidosis, severe dehydration, elevated blood pressure, markedly elevated BUN [39]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Risk factors:\u00a0 Severe acidosis, severe dehydration, elevated blood pressure, markedly elevated BUN [39]"}
{"id": "article-26827_68", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Etiology:\u00a0 Unclear, however initially thought to be to due rapid IV fluid replacement but this is now controversial as a recent PECARN study in 2018 showed no difference in neurological outcomes. [42]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Etiology:\u00a0 Unclear, however initially thought to be to due rapid IV fluid replacement but this is now controversial as a recent PECARN study in 2018 showed no difference in neurological outcomes. [42]"}
{"id": "article-26827_69", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Presents at any time before, during, or after treatment, but typically onset is within 12 hours of treatment. [39]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Presents at any time before, during, or after treatment, but typically onset is within 12 hours of treatment. [39]"}
{"id": "article-26827_70", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Signs/Symptoms:\u00a0 Altered mental status, new headache, recurrent vomiting, urinary incontinence, Cushing Triad (bradycardia, irregular respirations, hypertension)", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Signs/Symptoms:\u00a0 Altered mental status, new headache, recurrent vomiting, urinary incontinence, Cushing Triad (bradycardia, irregular respirations, hypertension)"}
{"id": "article-26827_71", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Cerebral Edema may not initially be seen on CT imaging of the brain, therefore may still require starting treatment even if the CT head is normal. [43]", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Cerebral Edema may not initially be seen on CT imaging of the brain, therefore may still require starting treatment even if the CT head is normal. [43]"}
{"id": "article-26827_72", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Treat if high suspicion: Mannitol (0.5-1 g/kg IV over 15 minutes): Osmotic diuretic causing withdrawing water from the brain parencyma. May give a second dose if there is no initial response. Hypertonic (3%) saline 2.5 mL/kg over 30 minutes", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Treat if high suspicion: Mannitol (0.5-1 g/kg IV over 15 minutes): Osmotic diuretic causing withdrawing water from the brain parencyma. May give a second dose if there is no initial response. Hypertonic (3%) saline 2.5 mL/kg over 30 minutes"}
{"id": "article-26827_73", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Neurosurgical consultation", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Neurosurgical consultation"}
{"id": "article-26827_74", "title": "Pediatric Diabetic Ketoacidosis -- Complications", "content": "Other Complications include: Cognitive impairment Venous thrombosis [44] Pancreatic enzyme elevations Acute kidney injury [45] Hypokalemia Hypoglycemia Rhabdomyolysis Pulmonary edema Multiple organ dysfunction syndrome Cardiac arrhythmias", "contents": "Pediatric Diabetic Ketoacidosis -- Complications. Other Complications include: Cognitive impairment Venous thrombosis [44] Pancreatic enzyme elevations Acute kidney injury [45] Hypokalemia Hypoglycemia Rhabdomyolysis Pulmonary edema Multiple organ dysfunction syndrome Cardiac arrhythmias"}
{"id": "article-26827_75", "title": "Pediatric Diabetic Ketoacidosis -- Deterrence and Patient Education", "content": "Education on the disease process of diabetes, including short and long-term complications, should be given to all patients. Parents and children should be taught how and when to check glucose. They should receive education about\u00a0how to use oral hypoglycemic meds\u00a0and/or insulin, medication, side effects, and the importance of compliance. Dietitians, nurses, and multi-disciplinary home health can be essential team members in assisting with this education.", "contents": "Pediatric Diabetic Ketoacidosis -- Deterrence and Patient Education. Education on the disease process of diabetes, including short and long-term complications, should be given to all patients. Parents and children should be taught how and when to check glucose. They should receive education about\u00a0how to use oral hypoglycemic meds\u00a0and/or insulin, medication, side effects, and the importance of compliance. Dietitians, nurses, and multi-disciplinary home health can be essential team members in assisting with this education."}
{"id": "article-26827_76", "title": "Pediatric Diabetic Ketoacidosis -- Pearls and Other Issues", "content": "Recurrent DKA is a\u00a0particular problem in adolescents and may be fatal. Early help is advised as soon as the DKA diagnosis is made. It may be precipitated by: Poor compliance or understanding of insulin therapy Infections Alcohol and substance\u00a0use disorders Psychological stress and\u00a0lifestyle changes Psychiatric disorders", "contents": "Pediatric Diabetic Ketoacidosis -- Pearls and Other Issues. Recurrent DKA is a\u00a0particular problem in adolescents and may be fatal. Early help is advised as soon as the DKA diagnosis is made. It may be precipitated by: Poor compliance or understanding of insulin therapy Infections Alcohol and substance\u00a0use disorders Psychological stress and\u00a0lifestyle changes Psychiatric disorders"}
{"id": "article-26827_77", "title": "Pediatric Diabetic Ketoacidosis -- Enhancing Healthcare Team Outcomes", "content": "Pediatric diabetic ketoacidosis is a life-threatening disorder best managed by an interprofessional team that includes an emergency department clinician, endocrinologist, pediatrician, intensivist, critical care nursing staff, and pharmacists. These individuals are best managed in the ICU and monitored by nurses. Providers should investigate the cause of DKA while providing initial hydration and correction of acidosis. Primary caregivers, pharmacists, and diabetes educators must work together\u00a0to ensure that the patient is compliant with insulin therapy and monitoring. Nurses can provide dosing for inpatients and can counsel all patients. Pharmacists will verify dosing and monitor potential drug interactions, providing counsel to patient parents. All interprofessional team members are responsible for documenting their observations, interactions, and interventions and informing other team members regarding the case, so additional interventions can be instituted if necessary. Interprofessional care is the best methodology for patient management in pediatric diabetic ketoacidosis. [Level 5]", "contents": "Pediatric Diabetic Ketoacidosis -- Enhancing Healthcare Team Outcomes. Pediatric diabetic ketoacidosis is a life-threatening disorder best managed by an interprofessional team that includes an emergency department clinician, endocrinologist, pediatrician, intensivist, critical care nursing staff, and pharmacists. These individuals are best managed in the ICU and monitored by nurses. Providers should investigate the cause of DKA while providing initial hydration and correction of acidosis. Primary caregivers, pharmacists, and diabetes educators must work together\u00a0to ensure that the patient is compliant with insulin therapy and monitoring. Nurses can provide dosing for inpatients and can counsel all patients. Pharmacists will verify dosing and monitor potential drug interactions, providing counsel to patient parents. All interprofessional team members are responsible for documenting their observations, interactions, and interventions and informing other team members regarding the case, so additional interventions can be instituted if necessary. Interprofessional care is the best methodology for patient management in pediatric diabetic ketoacidosis. [Level 5]"}
{"id": "article-26827_78", "title": "Pediatric Diabetic Ketoacidosis -- Enhancing Healthcare Team Outcomes", "content": "Any interprofessional team member who detects a change in status should immediately document their findings in the patient's medical record and notify other team members so corrective action can be taken to ensure optimal outcomes in this potentially very ill patient population. [46] [28] [47]", "contents": "Pediatric Diabetic Ketoacidosis -- Enhancing Healthcare Team Outcomes. Any interprofessional team member who detects a change in status should immediately document their findings in the patient's medical record and notify other team members so corrective action can be taken to ensure optimal outcomes in this potentially very ill patient population. [46] [28] [47]"}
{"id": "article-26827_79", "title": "Pediatric Diabetic Ketoacidosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Pediatric Diabetic Ketoacidosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}